Plasmalogen deficiency and neuropathology in Alzheimer's disease: Causation or coincidence?

Vijitha Senanayake1, Dayan B. Goodenowe1
1Prodrome Sciences Inc, Saskatoon, SK, Canada

Tóm tắt

AbstractCausation of Alzheimer's disease (AD) is not well understood. It is necessary to look beyond neuropathology to identify the underlying causes of AD and many other common neurological diseases. Lipid abnormalities are well documented in the preclinical phases of many neurological diseases including AD. Here, we use AD as an example to examine the role of lipid abnormalities as an underlying cause of neurodegeneration. Role of lipids, particularly phospholipids, in the optimal function of the nervous system, impact of the aberrations of phospholipid metabolism on β‐amyloid deposition and cholinergic neuronal function, epidemiological evidence on the association of phospholipids with AD, and preliminary data on the possible modulation of risk factors of AD by phospholipids are examined. Implications of these findings on diagnosis and prevention are also discussed.

Tài liệu tham khảo

Vespa J., 2018, Demographic turning points for the United States: Population projections for 2020 to 2060 Alzheimer's Disease Facts and Figures, 2018, Alzheimer's & Dementia, 367 10.1016/S1474-4422(07)70178-3 10.1016/j.jalz.2011.03.003 10.1007/s13524-017-0598-7 Chang C.Y., 2009, Essential fatty acids and human brain, Acta Neurol Taiwan, 18, 231 10.3389/fendo.2017.00060 10.1046/j.1471-4159.1998.71062528.x Lordan R., 2017, Phospholipids of Animal and Marine Origin: Structure, Function, and Anti‐Inflammatory Properties, Molecules, 22, 1, 10.3390/molecules22111964 10.1194/jlr.R200021-JLR200 10.1016/j.neuint.2010.12.004 10.3389/fphys.2013.00168 10.1007/978-0-387-77401-5 10.1007/BF02531202 10.1016/j.cger.2014.04.001 10.1016/j.bbalip.2003.12.010 10.1177/107385840100700308 10.1194/jlr.P700023-JLR200 Wood P.L., 2011, Alzheimer's Disease Pathogenesis‐Core Concepts, Shifting Paradigms and Therapeutic Targets 10.1503/jpn.090059 10.1074/jbc.M109.083311 10.1016/j.bbadis.2012.05.008 10.1016/j.ymgmr.2014.06.003 10.1186/s12944-019-1044-1 10.1016/j.bbalip.2014.11.005 10.1074/jbc.RA117.001629 10.1016/j.bbamcr.2006.08.017 10.1016/S0009-3084(97)00089-3 10.1007/s00401-011-0836-9 10.1126/science.7046051 10.1016/0197-0186(85)90127-5 10.1042/bj2320505 10.1100/2012/141240 10.1111/j.1471-4159.2010.07070.x 10.1016/j.neurobiolaging.2003.12.023 10.1038/nrneurol.2012.263 10.1074/jbc.R800009200 10.1016/j.nbd.2014.05.007 10.1161/ATVBAHA.116.307023 10.1194/jlr.R036095 Liao F., 2017, Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease, Curr Opin Lipidol, 28, 60, 10.1097/MOL.0000000000000383 10.1046/j.1471-4159.2001.00332.x 10.1038/nm.3466 10.1111/jnc.12368 Goodenowe D., 2014, Relation of plasmalogen biosynthesis to cognition and ad in older persons. Alzheimer's & Dementia, The J Alzheimer's Assoc, 10, 887 Mochizuki A., 2015, Serum plasmalogens, ApoE genotype, and the odds of converting from nci to MCI/ad or from MCI to Alzheimer's disease: A longitudinal analysis in elderly persons. Alzheimer's & Dementia, The J Alzheimer's Assoc, 11, P865 Goodenowe D.B., 2016, Apoe Genotype, Serum Plasmalogens, Brain Amyloid And Tangles, And Cognition: A Pre‐/Post‐Mortem Analysis In Elderly Persons. Alzheimer's & Dementia, The J Alzheimer's Assoc, 12, P1156 10.1371/journal.pone.0028539 10.1186/1476-511X-9-62 10.1186/1476-511X-10-227 10.1186/1476-511X-10-182 10.1016/j.bbr.2015.03.012 10.1371/journal.pone.0151020 10.1074/jbc.M115.656983 10.1073/pnas.081620098 10.1016/0006-8993(95)00931-F 10.1097/00005072-199907000-00008 10.2174/1570159X13666150716165726 10.2174/156720511795256008 10.1016/j.jalz.2013.08.279 10.1016/j.cell.2015.12.056 10.1016/j.ebiom.2017.02.012 10.1128/AEM.06968-11 10.1186/s12982-015-0037-4 10.1002/1873-3468.12788 10.3390/ijms161024600 10.1001/archneur.63.10.1402 10.3233/JAD-170866